Pioneering diagnostics
E.g., 30/09/2016
E.g., 30/09/2016

bioMérieux – First-Half 2016 Results

31 August, 2016

  • Strong growth in sales, up 10.9% at constant exchange rates and scope of consolidation:
    • €1,001 million in sales
    • Up 7.2% as reported
  • Sharp 22% improvement in contributive operating income before...

bioMérieux – Second-Quarter 2016 Business Review

18 July, 2016

  • Strong growth in sales, up 10.9%, at constant exchange rates and scope of consolidation in the first half of 2016:
  •   Sales reached €1,001 million
  •   Up 7...

bioMérieux enlarges its pathogen identification capability on VITEK® MS

With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases

06 July, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, announced the launch of the first CE-marked database and reagent kits for the identification of mycobacteria, Nocardia, and moulds in a MALDI-TOF1 Mass Spectrometry System. This innovative...

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients with elevated risk of mortality

Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients

01 July, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that it has received 510(k) clearance from the U.S....

bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products

   

01 June, 2016

bioMérieux, a global player in in vitro diagnostics and world leader in industrial microbiological control, announces the acquisition of Hyglos, a Bernried (Germany) - based company specializing in the detection of endotoxins. Founded...

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1 

Two joint research laboratories focused on a common goal: advancing medical research for the benefit of patients

31 May, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, and the Lyon Civil Hospitals today inaugurated new joint research laboratory facilities located within the Edouard Herriot Hospital in Lyon, renewing their collaboration agreement for five years and expanded their...

bioMérieux – First-Quarter 2016 Business Review

20 April, 2016

  • Solid growth in sales, up 11.5% at constant exchange rates and scope of consolidation
  • €489 million in sales
  • Up 9.1% as reported
  • ...

bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey1 of antibiotic use and resistance rates in hospitals

Huge discrepancies in antibiotic use practices between countries2nd line antibiotics2 too frequently prescribed

11 April, 2016

Marcy l’Étoile (France) - Antwerp (Belgium) – April 11, 2016 – bioMérieux, a world leader in the field of in vitro diagnostics and the Laboratory of Medical Microbiology of the University of Antwerp are proud to present, on the occasion of the ECCMID...

FilmArray® Torch is now FDA cleared with all 4 existing FilmArray® Panels and the system gets CE marked

BioFire receives FDA clearances for FilmArray® Torch with FilmArray® Blood Culture Identification Panel, Gastrointestinal Panel and Meningitis/Encephalitis Panel  FilmArray® Torch delivers high throughput, radically smaller footprint

08 April, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, LLC, its molecular biology affiliate, has received clearances from the U.S. Food and Drug Administration (FDA) to market the FilmArray® Torch for use with the...

bioMérieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories

22 March, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, and COPAN, a leading manufacturer of innovative pre-analytic solutions, are pleased to announce the first commercial success resulting from their alliance. The two companies signed a strategic partnership in January 2015...